FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/10/037674 [Registered on: 29/10/2021] Trial Registered Prospectively
Last Modified On: 29/10/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha
Screening 
Study Design  Single Arm Study 
Public Title of Study   A clinical trial to study the effect of the drug Kamalaiku kashayam in patients having Vali manjal noi(Fatty Liver Disease) 
Scientific Title of Study   Phase 2 Non randomized open clinical evaluation of siddha medicine Kamalaiku kashayam for the management of Vali manjal noi(Fatty Liver Disease) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrKuttalavadivu C 
Designation  PG Scholar 
Affiliation  Government Siddha Medical college 
Address  Post Graduate Department of General Medicine, Government Siddha Medical College ,Arumbakkam , Chennai-106

Chennai
TAMIL NADU
600106
India 
Phone  9361325072  
Fax    
Email  vadivubala1995@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrMenaka R 
Designation  Lecturer 
Affiliation  Government Siddha Medical College 
Address  Post graduate Department of General Medicine, Government Siddha Medical college, Arumbakkam, chennai-106

Chennai
TAMIL NADU
600106
India 
Phone  9444669661  
Fax    
Email  rangasamymenaka75@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrMenaka R 
Designation  Lecturer 
Affiliation  Government Siddha Medical College 
Address  Post graduate Department of General Medicine, Government Siddha Medical college, Arumbakkam, chennai-106

Chennai
TAMIL NADU
600106
India 
Phone  9444669661  
Fax    
Email  rangasamymenaka75@gmail.com  
 
Source of Monetary or Material Support  
Government Siddha Medical college , Arumbakkam, Chennai 106 
 
Primary Sponsor  
Name  Government Siddha Medical college 
Address  Government Siddha Medical College, Arumbakkam , Chennai-106 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrKuttala vadivu C  Arignar Anna Government hospital of Indian Medicine  Room no 2, Post Graduate Department of General Medicine
Chennai
TAMIL NADU 
9361325072

vadivubala1995@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E116||Type 2 diabetes mellitus with other specified complications,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Kamalaiku kashayam  30ml ,twice a day for 30 days 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Subject within 20-60years,
Grade 2 & Grade 1 fatty liver in USG abdomen
Metabolic syndrome(Type 2 Diabetes mellitus,Obesity)
Dyslipidemia 
 
ExclusionCriteria 
Details  Cirrhosis
HCC
Alcoholic fatty liver
Portal hypertension
Hepatitis (HBV,HCV infection)
Hepatosplenomegaly
Cholecystitis 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
It is mainly assessed by reduction in the clinical symptoms of abdominal discomfort, fat deposition, fatigue and abdominal pain  90days 
 
Secondary Outcome  
Outcome  TimePoints 
By comparing the fat deposition changes assessed by USG abdomen Grade 2 to Grade 1, Grade 1 to normal in liver USG study before and after treatment.  30days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/11/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a single non randomised open clinical trial to study the safety and efficacy of siddha trial drug Kamalaiku kashayam. The trial drug is given 30ml twice a day for 30 days. Clinical trial is conducted after conducting the preclinical toxicity study. The trial drug Kamalaiku kashayam is mentioned in Sikicha rathna deepam. During the trial all the study related data will be recorded and documented. After the completion of trial all the data will be analysed statistically. 
Close